Data / Form D filings / Lab7 Systems, Inc.
Lab7 Systems, Inc.: Form D filings
Lab7 Systems, Inc., a biotechnology company in Austin, TX, filed 11 Form D notices with the SEC between 2012 and 2016. The latest, on November 3, 2016, reports $1.5 million sold of a $1.5 million offering to 1 investor.
Find out what Lab7 Systems, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3101 BEVERLY ROAD, Austin, TX, 78703
- Phone
- (512) 565-9508
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2011
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1553175
The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 3, 2016 | New notice | $1,500,000 | $1,500,000 | $0 | 1 | Oct 26, 2016 | sec.gov |
| Jun 21, 2016 | New notice | $250,000 | $250,000 | $0 | 1 | Jun 15, 2016 | sec.gov |
| Jun 21, 2016 | Amendment | $400,000 | $215,000 | $185,000 | 3 | Jun 26, 2013 | sec.gov |
| Jul 15, 2014 | Amendment | $400,000 | $210,000 | $190,000 | 3 | Jun 26, 2013 | sec.gov |
| Dec 30, 2013 | Amendment | $400,000 | $155,000 | $245,000 | 3 | Jun 26, 2013 | sec.gov |
| Dec 30, 2013 | Amendment | $400,000 | $85,000 | $315,000 | 3 | Jun 26, 2013 | sec.gov |
| Nov 8, 2013 | Amendment | $400,000 | $130,000 | $270,000 | 8 | Jun 26, 2013 | sec.gov |
| Jul 9, 2013 | New notice | $400,000 | $60,000 | $340,000 | 3 | Jun 26, 2013 | sec.gov |
| Mar 29, 2013 | Amendment | $500,000 | $500,000 | $0 | 16 | Jun 15, 2012 | sec.gov |
| Jan 28, 2013 | Amendment | $500,000 | $465,000 | $35,000 | 14 | Jun 15, 2012 | sec.gov |
| Jun 29, 2012 | New notice | $500,000 | $210,000 | $290,000 | 5 | Jun 15, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Christopher Mueller | Executive Officer |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Oct 31, 2016 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Lab7 Systems, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.